Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Short-term Investments (2021 - 2022)

Biodesix filings provide 2 years of Short-term Investments readings, the most recent being $100000.0 for Q2 2022.

  • On a quarterly basis, Short-term Investments changed N/A to $100000.0 in Q2 2022 year-over-year; TTM through Jun 2022 was $100000.0, a N/A change, with the full-year FY2021 number at $100000.0, changed N/A from a year prior.
  • Short-term Investments hit $100000.0 in Q2 2022 for Biodesix, roughly flat from $100000.0 in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $100000.0 in Q4 2021 to a low of $100000.0 in Q4 2021.